<DOC>
	<DOC>NCT02128984</DOC>
	<brief_summary>The purpose of this study is to determine whether a nutritional supplement is effective in the treatment of malnutrition in pediatric patients with failure to thrive or cystic fibrosis.</brief_summary>
	<brief_title>Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children</brief_title>
	<detailed_description>This is a multicenter, controlled, randomized, prospective, parallel-group, double-blind study to evaluate the effect of a nutritional supplement on nutritional status in children with failure to thrive or cystic fibrosis. Patients will be randomized to receive either a symbiotic formula with DHA and antioxidants or a standard formula.</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Failure to Thrive</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Malnutrition (P / T &lt;1 SD) by intake deficit without organic disease (failure to thrive) and / or patients diagnosed with Cystic Fibrosis). Age &gt;= 1 year. Stable patients No antibiotherapy in the last 30 days Inform consent signed (parent/legal representative) Patients with allergy / intolerance to cow's milk proteins Metabolically unstable patient Patients with metabolic intolerance to carbohydrates Patients with severe disease in the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Malnutrition</keyword>
	<keyword>Dietary supplement</keyword>
	<keyword>Nutritional supplement</keyword>
	<keyword>Symbiotic formula</keyword>
	<keyword>DHA</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Failure to Thrive</keyword>
</DOC>